MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ESLAW
  4. News
ESLAW
Quote
Short
News
Articles
Message Board

Estrella Immunopharma Inc. Warrant (NASDAQ : ESLAW ) News

Estrella Immunopharma Inc. Warrant (NASDAQ: ESLAW) News Releases

ESLAW News Releases
ESLAW : NASDAQ
Business Wire
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
ESLAW : NASDAQ
BioMedWire
BioMedNewsBreaks - Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) Closes $8.0 Million Registered Direct Offering
ESLAW : NASDAQ
Business Wire
Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
ESLAW : NASDAQ
Business Wire
Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
ESLAW : NASDAQ
Business Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.